Human medicines
Peditrace
The marketing authorization holder informed its supplied customers in a letter dated June 18, 2013, that due to an individual complaint from the…
Cileste, TriCilest und Vivelle
The marketing authorization holder informed its supplied customers in a letter dated June 3, 2013, that in the course of stability tests after 24…
Magnegita
The marketing authorization holder has informed its supplied customers in a letter dated 24.05.2013 that particles were observed in some vials. For…
Ephedrine Streuli and Vitamin A Streuli
During a routine test, leaks in the area of the predetermined breaking point at the neck of an amber glass ampoule of the size 1 ml were discovered in…
Ibandronic acid
The marketing authorization holder informed its customers in a letter dated April 18, 2013, that due to a technical defect during production, isolated…
Magnesiocard
The marketing authorization holder has informed its supplied customers and medical home pharmacies that a microbiological contamination has been…
Desloratadine
The distributor informed its supplied customers that during stability tests after a storage period of more than two years the specifications of the…
Tredaptive
The marketing authorization holder has informed its supplied customers that preliminary results from the HPS2-THRIVE study (Heart Protection Study…
Cefuroxim
The marketing authorization holder informed its supplied customers in a letter dated Dec. 20, 2012, that the batch would be replaced due to unusual…
Urokinase 50.000 I.E.
The distributor has informed its supplied customers that the above batch was intended for Germany or was placed on the market in Austria in German…